Home  »  Markets   »  DermTech Inc. (DMTK) Volatility At 11.23%, Should ...

DermTech Inc. (DMTK) Volatility At 11.23%, Should You Add A Position?

133 institutions hold shares in DermTech Inc. (DMTK), with 4.7M shares held by insiders accounting for 16.34% while institutional investors hold 56.22% of the company’s shares. The shares outstanding are 19.71M, and float is at 19.71M with Short Float at 23.64%. Institutions hold 47.03% of the Float.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is RTW Investments LP with over 2.89 million shares valued at $93.66 million. The investor’s holdings represent 9.99% of the DMTK Shares outstanding. As of Dec 30, 2020, the second largest holder is Casdin Capital, LLC with 1.37 million shares valued at $44.44 million to account for 4.74% of the shares outstanding. The other top investors are Federated Hermes, Inc. which holds 1.09 million shares representing 3.78% and valued at over $35.46 million, while Farallon Capital Management LLC holds 2.98% of the shares totaling 0.86 million with a market value of $27.93 million.

DermTech Inc. (NASDAQ: DMTK) is 20.19% higher on its value in year-to-date trading and has touched a low of $9.64 and a high of $84.49 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DMTK stock was last observed hovering at around $38.13 in the last trading session, with the day’s gains setting it 0.86% off its average median price target of $64.00 for the next 12 months. It is also 50.65% off the consensus price target high of $79.00 offered by 5 analysts, but current levels are 22.02% higher than the price target low of $50.00 for the same period.

Currently trading at $38.99, the stock is -14.10% and -29.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.76 million and changing 2.26% at the moment leaves the stock 42.98% off its SMA200. DMTK registered 212.92% gain for a year compared to 6-month gain of 230.42%. The firm has a 50-day simple moving average (SMA 50) of $48.81 and a 200-day simple moving average (SMA200) of $34.91.

The stock witnessed a -24.54% loss in the last 1 month and extending the period to 3 months gives it a -9.16%, and is -10.29% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.23% over the week and 9.04% over the month.

DermTech Inc. (DMTK) has around 118 employees, a market worth around $1.10B and $5.90M in sales. Distance from 52-week low is 304.46% and -53.85% from its 52-week high. The company has generated returns on investments over the last 12 months (-55.30%).

DermTech Inc. (DMTK) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for DermTech Inc. (DMTK) is a “Buy”. 5 analysts offering their recommendations for the stock have an average rating of 1.60, where 0 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

DermTech Inc. quarterly earnings per share for the current quarter are estimated at -$0.43 with sales reaching $2.1M over the same period.The EPS is expected to grow by 26.10% this year, but quarterly earnings will post 107.60% year-over-year. Quarterly sales are estimated to grow 34.90% in year-over-year returns.

DermTech Inc. (DMTK) Insider Activity

The most recent transaction is an insider sale by Wood Todd Michael, the company’s Chief Commercial Officer. SEC filings show that Wood Todd Michael sold 10,000 shares of the company’s common stock on Apr 12 at a price of $46.33 per share for a total of $0.46 million. Following the sale, the insider now owns 0.16 million shares.

DermTech Inc. disclosed in a document filed with the SEC on Apr 12 that Dobak John (Chief Executive Officer) sold a total of 25,000 shares of the company’s common stock. The trade occurred on Apr 12 and was made at $46.34 per share for $1.16 million. Following the transaction, the insider now directly holds 0.54 million shares of the DMTK stock.

Still, SEC filings show that on Mar 08, Wood Todd Michael (Chief Commercial Officer) disposed off 417 shares at an average price of $50.04 for $20867.0. The insider now directly holds 164,782 shares of DermTech Inc. (DMTK).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam